Trelegy ellipta 200-62.5-25 60S
Ended Awarded
- Contract number
- SPE2DB25FP47A
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,381
Award facts
- Contract value 100% obligated
- $26,381.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $26,381.10 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25 60S, a combination inhalation medication used to treat chronic obstructive pulmonary disease. This firm fixed-price delivery order, awarded on July 28, 2025, is scheduled for completion by July 29, 2025, and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The award utilized no set-aside designation, indicating competitive procurement from the open market. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.9 billion global pharmaceutical support vehicle designated SPE2DX and active through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement across military and veteran healthcare systems. The company's extensive portfolio of federal contracts with the DLA encompasses a wide range of pharmaceutical products and medical supplies, including specialty medications, generic drugs, vaccines, and medical devices across multiple therapeutic domains. This delivery order for respiratory medication supports the Defense Health Agency's medical supply requirements and reflects the contractor's ongoing role in fulfilling the DLA's pharmaceutical distribution needs for the U.S. military healthcare system.
Quick answers
Who was awarded contract SPE2DB25FP47A?
SPE2DB25FP47A was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 28, 2025.
How much is contract SPE2DB25FP47A worth?
The government has obligated $26,381 on SPE2DB25FP47A.
Is contract SPE2DB25FP47A an order under another contract?
Yes. SPE2DB25FP47A is a delivery order under SPE2DB20D1109, an indefinite delivery contract.
Was contract SPE2DB25FP47A competed?
The extent of competition for SPE2DB25FP47A was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award